Condition

Restrictive Cardiomyopathy clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Restrictive Cardiomyopathy clinical trials that are recruiting, at sites in 3 countries (most in Italy (1), United States (1), France (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Restrictive Cardiomyopathy clinical trials

StudyPhaseWhereStatusRegistered
Registry for patients with non-ischemic cardiomyopathies — Milan, Milano Recruiting Sep 23, 2024
Registry for coronary artery disease and microvascular disease in cardiomyopathies — La Tronche Recruiting Mar 27, 2018
Analyzing genetic mutations in pediatric cardiomyopathy — Indianapolis, Indiana Recruiting May 1, 2015

All recruiting trials (3)

Related topics

Anderson-Fabry DiseaseArrhythmogenic Right Ventricular CardiomyopathyCardiomyopathiesDilated CardiomyopathyDilated Cardiomyopathy (DCM)Hypertrophic CardiomyopathyHypertrophic Cardiomyopathy (HCM)IschemicNon-ischemic Cardiomyopathy

Quick answers

How many Restrictive Cardiomyopathy clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Italy (1 trial), United States (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.